QuantaMatrix Inc. (KOSDAQ:317690)

South Korea flag South Korea · Delayed Price · Currency is KRW
4,155.00
-105.00 (-2.46%)
Last updated: Aug 14, 2025
-2.46%
Market Cap80.15B
Revenue (ttm)2.73B
Net Income (ttm)-19.99B
Shares Out19.29M
EPS (ttm)-1,198.42
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume90,842
Average Volume563,777
Open4,225.00
Previous Close4,260.00
Day's Range4,150.00 - 4,340.00
52-Week Range2,920.00 - 19,200.00
Beta0.14
RSI48.54
Earnings DateAug 14, 2025

About QuantaMatrix

QuantaMatrix Inc. operates as an in-vitro diagnostics company in South Korea. Its products include dRAST, a direct and rapid antimicrobial susceptibility test for treating sepsis that provides MIC-based phenotypic antimicrobial susceptibility testing direct from positive blood culture; QDST, a rapid phenotypic drug susceptibility testing system for tuberculosis; QPLEX Alz plus assay, an early diagnosis kit for Alzheimer's disease; and Quanti9 and QuantiGal, a prognostic prediction kit for cardiovascular diseases. QuantaMatrix Inc. was founded i... [Read more]

Industry Electromedical and Electrotherapeutic Apparatus
Founded 2010
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 317690
Full Company Profile

Financial Performance

In 2024, QuantaMatrix's revenue was 2.50 billion, a decrease of -19.91% compared to the previous year's 3.12 billion. Losses were -20.17 billion, -6.44% less than in 2023.

Financial Statements

News

There is no news available yet.